abstract |
The invention relates to chimeric antigen receptors (CARs) having antigen specificity for B cell processing antigen (BCMA). The invention also relates to nucleic acids, recombinant expression vectors, host cells, cell populations, and pharmaceutical compositions relating to CARs. The invention further provides methods of treating and preventing cancer in a mammal. |